Weekly epidoxorubicin therapy in hormone-refractory metastatic prostate cancer.
Neri B, Barbagli G, Bellesi P, Di Loro R, Lombardi V, Lombardo C, Magrini T, Mottola A, Nicita G, Palminteri E, Ponchietti R, Raugei A, Intini C.
Neri B, et al. Among authors: mottola a.
Anticancer Res. 1997 Sep-Oct;17(5B):3817-20.
Anticancer Res. 1997.
PMID: 9427786